📋 FDA Reference

Philips Integris Allura Flat Detector Release 1 2

Philips Medical Systems North America

Compare similar devices

Summary: The Philips Integris Allura Flat Detector is a medical imaging device used primarily in interventional radiology and cardiology for procedures like embolization. It is utilized by radiologists and cardiologists to visualize blood vessels and guide interventions.

FDA Clearance Information

Pathway ? 510(k)
Number ? K031333 ↗
Decision Date ? May 13, 2003
Product Code ? IZI
Device Class ? Class 2
Evidence ? 419 studies

The Philips Integris Allura Flat Detector was cleared through the FDA 510(k) pathway on May 13, 2003. Manufactured by Philips Medical Systems North America, it is classified as a Class 2 device under product code IZI.

What It Is

The Philips Integris Allura Flat Detector is an advanced imaging system designed for use in interventional procedures. It utilizes flat-panel detector technology to provide high-resolution, real-time X-ray images. This system enhances the clinician's ability to visualize complex vascular structures and guide therapeutic interventions with precision.

FDA-Cleared Indications

  • Use as a diagnostic X-ray imaging system for fluoroscopy and angiography.
  • Use to provide real-time X-ray imaging during interventional procedures.
  • Use for visualization during procedures involving liquid embolization agents, as specified in the applicable labeling.

Clinical Applications

  • Fluoroscopic and angiographic imaging during vascular procedures.
  • Image guidance for embolization procedures involving liquid embolization agents.
  • Visualization of blood vessels during catheter-based interventions.
  • Real-time imaging to support device positioning and procedural monitoring.

Reported off-label uses

  • Neurovascular angiography and image guidance for selected endovascular procedures may be performed with this type of system, depending on the installed configuration and facility protocols.
  • Image guidance for nonvascular fluoroscopic interventions may be possible, but use must follow the system labeling, configuration, and institutional policies.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • This is a fixed fluoroscopy and angiography system, not an implantable device or an MRI scanner.
  • Image quality and available applications depend on the installed detector, C-arm configuration, software version, accessories, and facility-specific options.
  • The system uses ionizing radiation; radiation dose should be managed with appropriate collimation, exposure settings, shielding, and monitoring.
  • Compatible catheters, guidewires, embolic agents, contrast media, and other devices must be selected according to their own labeling and the imaging system's technical specifications.
  • Regular preventive maintenance, calibration, quality-control testing, and operator training are required. It is not MRI safe as a complete system and should not be taken into the MRI scanner room unless specifically evaluated and approved for that environment.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Philips Integris Allura Flat Detector used for?

It is used for imaging and guiding interventional procedures in radiology and cardiology, such as embolization and angioplasty.

What specialties typically use this device?

Interventional radiologists and cardiologists primarily use this device in hospital and specialized clinic settings.

What are the FDA-cleared indications?

The device is indicated for use in procedures involving liquid embolization agents, aiding in the treatment of vascular conditions.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you